Published by Fusion Animation on: 17 Sep 2024
Congratulations to LabGenius who recently announced a £35 million Series B fundraise.
We were approached by LabGenius to create a video demonstrating how they create drug candidates, how the drugs work at a molecular level and their benefits vs other formats. The goal was to help explain the unique ML-driven antibody discovery platform to investors.
You can watch the video we created here: https://www.fusionanimation.co.uk/clinical-areas/ai/